Literature DB >> 16426905

Rapid determination of valsartan in human plasma by protein precipitation and high-performance liquid chromatography.

J Macek1, J Klíma, P Ptácek.   

Abstract

A high-performance liquid chromatographic (HPLC) method for the determination of valsartan in human plasma is reported. The assay is based on protein precipitation with methanol and reversed-phase chromatography with fluorimetric detection. The preparation of a batch of 24 samples takes 20 min. The liquid chromatography was performed on an octadecylsilica column (50 mm x 4 mm, 5 microm particles), the mobile phase consisted of acetonitrile -15 mM dihydrogenpotassium phosphate, pH 2.0 (45:55, v/v). The run time was 2.8 min. The fluorimetric detector was operated at 234/374 nm (excitation/emission wavelength). The limit of quantitation was 98 ng/ml using 0.2 ml of plasma. Within-day and between-day precision expressed by relative standard deviation was less than 5% and inaccuracy did not exceed 8%. The assay was applied to the analysis of samples from a pharmacokinetic study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16426905     DOI: 10.1016/j.jchromb.2005.12.035

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  14 in total

1.  Preparation and bioavailability assessment of SMEDDS containing valsartan.

Authors:  Adhvait R Dixit; Sadhana J Rajput; Samir G Patel
Journal:  AAPS PharmSciTech       Date:  2010-02-25       Impact factor: 3.246

2.  Valsartan orodispersible tablets: formulation, in vitro/in vivo characterization.

Authors:  Howida Kamal Ibrahim; Doaa A El-Setouhy
Journal:  AAPS PharmSciTech       Date:  2010-01-29       Impact factor: 3.246

3.  A Simple, Rapid and Reliable Method to Determine Imipramine and Desipramine in Mouse Serum Using Ultra-High-Performance Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometry.

Authors:  Jing Zhao; Yujin Shin; Kwang-Hoon Chun; Hye-Ran Yoon; Jeongmi Lee
Journal:  J Chromatogr Sci       Date:  2015-12-19       Impact factor: 1.618

4.  Development and validation of a specific stability indicating high performance liquid chromatographic method for valsartan.

Authors:  Ks Rao; N Jena; Meb Rao
Journal:  J Young Pharm       Date:  2010-04

5.  Simultaneous Estimation of Nebivolol Hydrochloride and Valsartan using RP HPLC.

Authors:  S U Kokil; M S Bhatia
Journal:  Indian J Pharm Sci       Date:  2009-03       Impact factor: 0.975

6.  HPTLC Method for the Simultaneous Estimation of Valsartan and Hydrochlorothiazide in Tablet Dosage Form.

Authors:  N J Shah; B N Suhagia; R R Shah; N M Patel
Journal:  Indian J Pharm Sci       Date:  2009-01       Impact factor: 0.975

7.  Formulation and bioequivalence of two valsartan tablets after a single oral administration.

Authors:  Abdel Naser Zaid; Rita Cortesi; Aiman Qaddomi; Saed Khammash
Journal:  Sci Pharm       Date:  2010-11-20

8.  Simultaneous determination of amlodipine and valsartan.

Authors:  Nashwah Gadallah Mohamed
Journal:  Anal Chem Insights       Date:  2011-08-28

9.  Development and Validation of a LC-MS/MS Method for the Simultaneous Estimation of Amlodipine and Valsartan in Human Plasma: Application to a Bioequivalence Study.

Authors:  Hemanth Jangala; Poonam Vats; Arshad Hussain Khuroo; Tausif Monif
Journal:  Sci Pharm       Date:  2014-03-26

10.  Development of an HPLC-UV Method for the Analysis of Drugs Used for Combined Hypertension Therapy in Pharmaceutical Preparations and Human Plasma.

Authors:  Serife Evrim Kepekci Tekkeli
Journal:  J Anal Methods Chem       Date:  2013-03-24       Impact factor: 2.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.